At Sat, 18 Jan 2003, kann wrote:
> >-------Original Message------- > >From: Questionable Doctors Health Update
Date: Friday, January 17, 2003 11:46:49 AM
>To: HEALTHUPDATE@LISTSERVER.CITIZEN.ORG >Subject: New Prescription Drug Resource from Public Citizen > >From: Dr. Sidney Wolfe > >Within the next 12 months, it is likely that a prescription medication y u >or a loved one is taking will be discussed in Worst Pills, Best Pills Ne s >Online. > >Over 1 million Americans die or suffer from dangerous drug-induced illne s >every year. Learn how to protect yourself and your family from dangerous >medications by reading Public Citizen's newest online publication, Worst >Pills, Best Pills News Online. Visit http://www.worstpills.org/qdhu for a >FREE sample issue and also more information about our introductory >subscription offer, which includes: > >- 12 monthly online issues of Worst Pills, Best Pills News Online with t e >latest news and warnings on medications. Each month we will deliver the >latest issue's Table of Contents directly to your computer. > >- Archive of back issues from January 2001 to the present searchable by rug >name, disease or condition, or drug-induced adverse effect. > >- E-mail alerts about new drug dangers from the U.S. Food and Drug >Administration and other sources. > >- Lifesaving information on adverse drug reactions including: 148 drugs hat >can cause depression; 128 drugs that can cause sexual dysfunction; and 36 >drugs that can cause Parkinsonism. > >------------------------------------------------------------ > =0D >------------------------------------------------------------ >------------------------------------------------------------ >------------------------------------------------------------ >Worstpills.org is supported by the Health Research Group staff, with a wi>------------------------------------------------------------ >de >------------------------------------------------------------ >scope of medical expertise concerning prescription drugs: >------------------------------------------------------------ > >Elizabeth Barbehenn, PhD, was trained as a biochemist and was a research r >at the National Institutes of Health for 10 years. Subsequently, she wor ed >for the Food and Drug Administration as a pharmacologist for 13 years >analyzing toxicity data from animal studies on prescription drugs. She h s >been with our group since 1998 where she continues her work analyzing dr g >safety. > >Deanne E. Knapp, PhD was trained as a social psychologist. From 1971 to 002 > she was Adjunct Professor, School of Pharmacy, University of Maryland w ere >she taught and performed research on the topic of drug utilization. Duri g >the same time period, she was a Technical Information Specialist with the >FDA where she designed electronic systems to detect and monitor the >reporting of adverse drug reactions. > >Peter Lurie, MD, MPH is the Deputy Director of the Health Research Group He >has held faculty positions at the University of California, San Francisco >and the University of Michigan. After obtaining his medical degree from he >Albert Einstein College of Medicine, he completed residencies in Family >Practice and Preventive Medicine/epidemiology. He has written on the sub ect >of needle exchange programs and on ethical aspects of drug and vaccine >trials in developing countries and has authored articles on the safety a d >effectiveness of various drugs. > >Larry Sasich, PharmD, MPH, FASHP has experience in community and hospital >pharmacy and in pharmacy education, teaching the first required course in >drug information while a faculty member at the Idaho State University >College of Pharmacy. Dr. Sasich has a long-standing interest in the >dissemination of objective drug information to both health professionals and >the public. He has been the principal author of Worst Pills, Best Pills ews >since coming to the Health Research Group in 1995. > >Paul Stolley, MD is a practicing internist who has spent more than three >decades as a teacher and research epidemiologist at Johns Hopkins School of >Public Health, the University of Pennsylvania School of Medicine and fin lly >as Chair of the Department of Epidemiology and Preventive Medicine at the >University of Maryland School of Medicine. His main research interests a e >adverse drug reactions and prevention of cancer. He has co-authored three >books in the field of epidemiology and over 200 articles. He recently sp nt >a sabbatical year at the FDA in the division conducting post market >surveillance of drugs. He is a member of the Institute of Medicine of the >National Academy of Sciences and a former President of the American Coll ge >of Epidemiology and the Society for Epidemiologic Research. > >Sidney Wolfe, MD, has been the Director of the Health Research Group sin e >its creation in 1971. Having previously done research on drug toxicity, n >1966 he began working at the National Institutes of Health where he did >research on aspects of blood-clotting. Since 1995, he has been an Adjunct >Professor of Internal Medicine at the Case Western Reserve University Sc ool >of Medicine. His medical degree is from Case Western University in Cleve and > Ohio and his internship and residency were in internal medicine. He is >currently a member of the Society for General Internal Medicine. His awa ds >include receiving the MacArthur Foundation Fellowship in 1990.